Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED)

v3.20.2
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Earnings
Beginning Balance at Dec. 31, 2018 $ 201,100 $ 11,021 $ 102,243 $ 87,836
Beginning Balance (in shares) at Dec. 31, 2018   15,090    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (3,042)     (3,042)
Vesting of restricted stock (714) $ (71) (643)  
Vesting of restricted stock (in shares)   146    
Stock-based compensation expense 560 $ 56 504  
Ending Balance at Mar. 31, 2019 197,904 $ 11,006 102,104 84,794
Ending Balance (in shares) at Mar. 31, 2019   15,236    
Beginning Balance at Dec. 31, 2018 201,100 $ 11,021 102,243 87,836
Beginning Balance (in shares) at Dec. 31, 2018   15,090    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (15,069)      
Ending Balance at Sep. 30, 2019 187,044 $ 11,123 103,154 72,767
Ending Balance (in shares) at Sep. 30, 2019   15,263    
Beginning Balance at Mar. 31, 2019 197,904 $ 11,006 102,104 84,794
Beginning Balance (in shares) at Mar. 31, 2019   15,236    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (5,248)     (5,248)
Stock-based compensation expense 786 $ 79 707  
Ending Balance at Jun. 30, 2019 193,442 $ 11,085 102,811 79,546
Ending Balance (in shares) at Jun. 30, 2019   15,236    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (6,779)     (6,779)
Vesting of restricted stock (81) $ (8) (73)  
Vesting of restricted stock (in shares)   27    
Stock-based compensation expense 462 $ 46 416  
Ending Balance at Sep. 30, 2019 187,044 $ 11,123 103,154 72,767
Ending Balance (in shares) at Sep. 30, 2019   15,263    
Beginning Balance at Dec. 31, 2019 $ 152,685 $ 11,119 103,124 38,442
Beginning Balance (in shares) at Dec. 31, 2019 15,263 15,263    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) $ 5,905     5,905
Vesting of restricted stock (73) $ (8) (65)  
Vesting of restricted stock (in shares)   27    
Stock-based compensation expense 95 $ 10 85  
Ending Balance at Mar. 31, 2020 158,612 $ 11,121 103,144 44,347
Ending Balance (in shares) at Mar. 31, 2020   15,290    
Beginning Balance at Dec. 31, 2019 $ 152,685 $ 11,119 103,124 38,442
Beginning Balance (in shares) at Dec. 31, 2019 15,263 15,263    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) $ (11,969)      
Ending Balance at Sep. 30, 2020 $ 141,423 $ 11,189 103,761 26,473
Ending Balance (in shares) at Sep. 30, 2020 15,325 15,325    
Beginning Balance at Mar. 31, 2020 $ 158,612 $ 11,121 103,144 44,347
Beginning Balance (in shares) at Mar. 31, 2020   15,290    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (5,537)     (5,537)
Vesting of restricted stock (1)   (1)  
Vesting of restricted stock (in shares)   19    
Stock-based compensation expense 345 $ 34 311  
Ending Balance at Jun. 30, 2020 153,419 $ 11,155 103,454 38,810
Ending Balance (in shares) at Jun. 30, 2020   15,309    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (12,337)     (12,337)
Vesting of restricted stock (in shares)   16    
Stock-based compensation expense 341 $ 34 307  
Ending Balance at Sep. 30, 2020 $ 141,423 $ 11,189 $ 103,761 $ 26,473
Ending Balance (in shares) at Sep. 30, 2020 15,325 15,325